These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19304450)

  • 1. Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation.
    Fukuda D; Enomoto S; Nagai R; Sata M
    Biomed Pharmacother; 2009 Dec; 63(10):754-61. PubMed ID: 19304450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
    Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits.
    Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertens Res; 2008 Mar; 31(3):575-84. PubMed ID: 18497479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
    Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
    Montanaro D; Gropuzzo M; Tulissi P; Vallone C; Boscutti G; Mioni R; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    Transplant Proc; 2005 Mar; 37(2):991-3. PubMed ID: 15848600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice.
    Fukuda D; Sata M; Ishizaka N; Nagai R
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):90-6. PubMed ID: 17962627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
    J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V; Mueller CF; Becher UM; Czech T; van Eickels M; Daiber A; Nickenig G; Wassmann S
    J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
    Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
    Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
    Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.